Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Vaccine-for-cytomegalovirus

 Phosphoramidate and phosphorothioamidate oligomeric compounds
OF THE INVENTION Compounds of the invention are shown by Structure I above. In Structure I, the ...


 System to detect protein-protein interactions
These and other objects are achieved by the present invention which provides a method and a kit for ...


 Methods for lymph node identification
The present invention describes materials and methods for the identification of sentinel lymph ...


 Method for determining virulence of Yersinia
What is claimed is: 1. A method for determining virulence of a Yersinia strain, said method ...


 Compositions and methods for the oral delivery of active agents
What is claimed is: 1. A method for systemically delivering a protein or polypeptide drug to a ...


 Vaccine containing a Shigella bacterium having an enhanced antigenic property
This invention provides defined culture conditions and components incorporated into growth media of ...


 Use of purified invaplex from gram negative bacteria as a vaccine
The present invention relates to a vaccine for gram-negative bacteria based on Invaplex and to ...


 Method for producing a nematocidal composition by heat treating a pH-adjusted fermentation broth
OF THE INVENTION To produce a nematocidal preparation, a substantial amount of biomass is prepared ...


 Viruses comprising mutant ion channel protein
OF THE INVENTION Definitions As used herein, the terms "isolated and/or purified" refer to in ...


 Steroid-activated nuclear receptors and uses therefor
OF THE INVENTION In accordance with the present invention, a new class of receptors has been ...


 Vaccine for cytomegalovirus

Details
Inventors: Pereira, Lenore;
Assignee: Institut Merieux (Charbonnieres, FR)
Primary Examiner: Foelak; Morton
Assistant Examiner: Draper; Garnette D.
Attorney, Agent or Firm: Rowland; Bertram I.

A novel subunit vaccine employing glycoprotein A of human cytomegalovirus or fragments thereof is provided. The vaccine is particularly suitable for inoculation of immunosuppressed individuals and women of childbearing age to inhibit the transmission of hCMV to the fetus.

DETAILED DESCRIPTION What is claimed is: 1.
A method for vaccinating a susceptible host to confer humoral immunity to human cytomegalovirus (hCMV), said method comprising inoculating the host with a polypeptide having immunological activity cross-reactive with that of glycoprotein A of cytomegalovirus and having substantially the same sequence as naturally-occurring glycoprotein A, said polypeptide being present in a physiologically-acceptable carrier in an amount effective to elicit viral neutralizing activity against the cytomegalovirus.
2.
A method as in claim 1, wherein the glycoprotein A is isolated from hCMV-infected cells.
3.
A method as in claim 1, wherein the glycoprotein A is isolated by extraction in a non-ionic detergent followed by adsorption in an immunoaffinity column.
4.
A method as in claim 1, wherein the glycoprotein A is a mixture of different antigenically related forms having varying amounts of glycosylation and different electrophoretic properties.
5.
A vaccine against human cytomegalovirus (hCMV) infection, said vaccine comprising a polypeptide having immunological activity cross-reactive with glycoprotein A of the cytomegalovirus and having substantially the same sequence as naturally-occurring glycoprotein A, said polypeptide being present in an immunologically acceptable carrier in an amount effective to elicit viral neutralizing activity against cytomegalovirus when administered to a susceptible host.
6.
A vaccine as in claim 5, wherein the glycoprotein A is isolated from hCMV-infected cells.
7.
A vaccine as in claim 6, wherein the glycoprotein A is isolated by extraction in a non-ionic detergent followed by adsorption to an affinity column.
8.
A vaccine as in claim 5, wherein the glycoprotein A is a mixture of different antigenically related forms having varying amounts of glycosylation and different electrophoretic properties.




Description:
BACKGROUND OF THE INVENTION 1.
Field of the Invention Vaccination against both bacterial and viral diseases has been one of the major accomplishments of medicine over the past century



Related patents
  Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
Methods and compositions are provided for labeling T cells according to the specificity of their antigen receptor. A stable multimeric complex is prepared with major ...
  Immuno-reactive peptide CTL epitopes of human cytomegalovirus
OF THE PREFERRED EMBODIMENTS According to one aspect of the present invention, a nonapeptide (9 amino acid peptide) of the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID ...
  CTL epitope analogs
Accordingly, this invention comprises a method of producing a human cytomegalovirus peptide cytotoxic T lymphocyte epitope analog with improved immunogenic potency and ...
  HCMV-reactive T cells and uses therefor
OF THE PREFERRED EMBODIMENTS A nonapeptide having the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID NO:1) is an immunogenic epitope of pp65 from CMV laboratory strains A...
  Immuno-reactive peptide CTL epitopes of human cytomegalovirus
Accordingly, one aspect of the present invention relates to immunologically active peptides, and functional variants thereof, capable of eliciting a cellular immune ...
  Synthetic peptide having an ionophoric and antimicrobial activity
OF THE INVENTION Synthetic peptide P1 of the present invention is comprised by 26 amino acids. The natural existence of this peptide in bacteria and animals has not ...
  Anti-TNF antibodies and peptides of human tumor necrosis factor
It is the object of the present invention to overcome one or more deficiencies of the background art. It is also an object of the present invention to provide methods ...
  Rod-coil block polyimide copolymers
What is claimed is: 1. Rod-coil block copolymers having polyimide rod segments alternating with polyether coil segments derived from the reaction of approximately 20 to 5...
  System to detect protein-protein interactions
These and other objects are achieved by the present invention which provides a method and a kit for detecting interactions between proteins, in vivo, using ...
  Production of antibodies from transgenic animals
We claim: 1. A transgenic mouse which has had inserted into its genome DNA comprising human Vh, human Dh, human Jh segments and human mu segments of human ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved